Company news
Twist Bioscience Corporation (NASDAQ:TWST) news
Twist Bioscience Corporation news releases on 6ix. Latest, Apr 13, 2023: Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday…
Press releases — page 3
Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
April 12, 2023
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
April 12, 2023
Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
March 8, 2023
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery Using New Methodology on Optofluidic Platform
February 13, 2023
Twist Bioscience Announces Technology Early Access of Enhanced Whole Genome Sequencing Solution at AGBT
February 6, 2023
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
February 2, 2023
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
January 25, 2023
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
January 18, 2023
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
January 9, 2023
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
January 8, 2023
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
January 2, 2023
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
November 17, 2022
Twist Bioscience Addresses Misleading Short-Seller Report
November 14, 2022
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
November 2, 2022
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
November 1, 2022
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
October 25, 2022
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
October 17, 2022
Twist Bioscience Earns 2022 Great Place to Work Certification
October 11, 2022
Twist Bioscience to Present at JSNN NanoImpacts 2022
October 4, 2022
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
September 19, 2022
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
September 5, 2022
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
August 4, 2022
Twist Bioscience to Present at Flash Memory Summit
August 2, 2022
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
August 1, 2022
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
August 1, 2022
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
July 31, 2022
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
July 17, 2022
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
July 13, 2022
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
July 12, 2022
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
July 5, 2022
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
June 29, 2022
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
June 15, 2022
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
June 6, 2022
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
May 30, 2022
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
May 17, 2022
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
May 9, 2022
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
May 8, 2022
Twist Bioscience Reports Second Quarter 2022 Financial Results
May 4, 2022
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
May 1, 2022
Twist Bioscience Launches High Throughput Antibody Production Platform
April 27, 2022
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
April 20, 2022
Twist Bioscience Announces Promotions and Changes to Executive Leadership Team
April 20, 2022
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022
April 17, 2022
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
April 6, 2022
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
April 4, 2022
Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules
March 20, 2022
Abveris Named as One of the Best Places to Work
March 9, 2022
Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy
March 8, 2022
Twist Bioscience to Present at Upcoming Virtual Conferences
February 27, 2022